This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Intrexon Corporation. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Charlotte, NC (US) (2013)
- Blacksburg, VA (US) (2015)
Company Filing History:
Years Active: 2013-2015
Title: The Innovative Contributions of David Bachinsky
Introduction
David Bachinsky is a notable inventor based in Charlotte, NC (US). He has made significant contributions to the field of biotechnology, particularly in the development of kinase ligands and polyligands. With a total of three patents to his name, Bachinsky's work has the potential to impact both research and therapeutic applications.
Latest Patents
Bachinsky's latest patents focus on MEK ligands and polynucleotides encoding MEK ligands. These inventions relate to kinase ligands and polyligands that modulate MEK activity. The ligands and polyligands serve as valuable research tools or therapeutics. His inventions also include the linkage of these ligands to cellular localization signals, epitope tags, and/or reporters. Additionally, the patents encompass polynucleotides that encode the ligands and polyligands, further enhancing their utility in scientific research.
Career Highlights
David Bachinsky is currently associated with Intrexon Corporation, where he continues to innovate and develop new technologies. His work at Intrexon has allowed him to collaborate with other talented professionals in the field, contributing to advancements in biotechnology.
Collaborations
Some of his notable coworkers include Thomas David Reed and Amy Hobbs Atzel. Their collaborative efforts have likely played a role in the successful development of Bachinsky's inventions.
Conclusion
David Bachinsky's contributions to the field of biotechnology through his innovative patents demonstrate his commitment to advancing scientific research and therapeutic applications. His work continues to influence the landscape of kinase research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
